MedTrace Logo

Swedish CArdioPulmonary bioImage Study 2

NCT06679777 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30154

Last updated 2024-11-07

No results posted yet for this study

Summary

In the Swedish CArdioPulmonary bioImage Study (SCAPIS 1), 30,154 randomly selected men and women, aged 50-64 years, were recruited from six areas in Sweden during 2013-2018. The study population was investigated with CCTA, ultrasound carotids, physical examination, questionnaires, accelerometry, ECG, spirometry, and biochemical markers. The aim was to obtain new information relevant to the identification and treatment of individuals with cardiopulmonary and metabolic diseases and to optimize the possibilities for studying disease mechanisms.

In SCAPIS-2, half of the individuals (n≈15,000) included in SCAPIS 1, will be re-examined 2024-2025 with the same investigations as during 2013-2018 except for ultrasound of the carotids.

Conditions

Sponsors & Collaborators

  • Lund University

    collaborator OTHER

  • Uppsala University

    collaborator OTHER

  • Umeå University

    collaborator OTHER

  • Linkoeping University

    collaborator OTHER_GOV

  • Göteborg University

    collaborator OTHER

  • Karolinska Institutet

    lead OTHER

Principal Investigators

  • Carl Johan Östgren, PhD · Linkoeping University

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-15
Primary Completion
2025-12-31
Completion
2030-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06679777 on ClinicalTrials.gov